These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19653273)

  • 1. Validation of predictive models for germline mutations in DNA mismatch repair genes in colorectal cancer.
    Monzon JG; Cremin C; Armstrong L; Nuk J; Young S; Horsman DE; Garbutt K; Bajdik CD; Gill S
    Int J Cancer; 2010 Feb; 126(4):930-9. PubMed ID: 19653273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Lynch syndrome in consecutive patients with colorectal cancer.
    Green RC; Parfrey PS; Woods MO; Younghusband HB
    J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients.
    Balmaña J; Balaguer F; Castellví-Bel S; Steyerberg EW; Andreu M; Llor X; Jover R; Castells A; Syngal S;
    J Med Genet; 2008 Sep; 45(9):557-63. PubMed ID: 18603628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive models for mutations in mismatch repair genes: implication for genetic counseling in developing countries.
    Monteiro Santos EM; Valentin MD; Carneiro F; de Oliveira LP; de Oliveira Ferreira F; Junior SA; Nakagawa WT; Gomy I; de Faria Ferraz VE; da Silva Junior WA; Carraro DM; Rossi BM
    BMC Cancer; 2012 Feb; 12():64. PubMed ID: 22321913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of Lynch syndrome predictive models in a multi-center US referral population.
    Khan O; Blanco A; Conrad P; Gulden C; Moss TZ; Olopade OI; Kupfer SS; Terdiman J
    Am J Gastroenterol; 2011 Oct; 106(10):1822-7; quiz 1828. PubMed ID: 21747416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of Prediction Models for Mismatch Repair Gene Mutations in Koreans.
    Lee SY; Kim DW; Shin YK; Ihn MH; Lee SM; Oh HK; Ku JL; Jeong SY; Lee JB; Ahn S; Won S; Kang SB
    Cancer Res Treat; 2016 Apr; 48(2):668-75. PubMed ID: 26044159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the clinical prediction model PREMM(1,2,6) and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer.
    Kastrinos F; Steyerberg EW; Balmaña J; Mercado R; Gallinger S; Haile R; Casey G; Hopper JL; LeMarchand L; Lindor NM; Newcomb PA; Thibodeau SN; Syngal S;
    Gut; 2013 Feb; 62(2):272-9. PubMed ID: 22345660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of germline mutations and cancer risk in the Lynch syndrome.
    Chen S; Wang W; Lee S; Nafa K; Lee J; Romans K; Watson P; Gruber SB; Euhus D; Kinzler KW; Jass J; Gallinger S; Lindor NM; Casey G; Ellis N; Giardiello FM; Offit K; Parmigiani G;
    JAMA; 2006 Sep; 296(12):1479-87. PubMed ID: 17003396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic.
    Lipton LR; Johnson V; Cummings C; Fisher S; Risby P; Eftekhar Sadat AT; Cranston T; Izatt L; Sasieni P; Hodgson SV; Thomas HJ; Tomlinson IP
    J Clin Oncol; 2004 Dec; 22(24):4934-43. PubMed ID: 15611508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Criteria and prediction models for mismatch repair gene mutations: a review.
    Win AK; Macinnis RJ; Dowty JG; Jenkins MA
    J Med Genet; 2013 Dec; 50(12):785-93. PubMed ID: 23956446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsatellite instability in saliva from patients with hereditary non-polyposis colon cancer and siblings carrying germline mismatch repair gene mutations.
    Hu P; Lee CW; Xu JP; Simien C; Fan CL; Tam M; Ramagli L; Brown BW; Lynch P; Frazier ML; Siciliano MJ; Coolbaugh-Murphy M
    Ann Clin Lab Sci; 2011; 41(4):321-30. PubMed ID: 22166501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of Lynch syndrome predictive models in quantifying the likelihood of germline mutations in patients with abnormal MLH1 immunoexpression.
    Cabreira V; Pinto C; Pinheiro M; Lopes P; Peixoto A; Santos C; Veiga I; Rocha P; Pinto P; Henrique R; Teixeira MR
    Fam Cancer; 2017 Jan; 16(1):73-81. PubMed ID: 27581132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation and extension of the PREMM1,2 model in a population-based cohort of colorectal cancer patients.
    Balaguer F; Balmaña J; Castellví-Bel S; Steyerberg EW; Andreu M; Llor X; Jover R; Syngal S; Castells A;
    Gastroenterology; 2008 Jan; 134(1):39-46. PubMed ID: 18061181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation prediction models in Lynch syndrome: evaluation in a clinical genetic setting.
    Ramsoekh D; van Leerdam ME; Wagner A; Kuipers EJ; Steyerberg EW
    J Med Genet; 2009 Nov; 46(11):745-51. PubMed ID: 19541685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: The Lynch syndrome (hereditary nonpolyposis colorectal cancer).
    Vasen HF
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():113-26. PubMed ID: 18081655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: are all mutations equal?
    Maccaroni E; Bracci R; Giampieri R; Bianchi F; Belvederesi L; Brugiati C; Pagliaretta S; Del Prete M; Scartozzi M; Cascinu S
    Oncotarget; 2015 Nov; 6(36):38737-48. PubMed ID: 26485756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing.
    Ferguson SE; Aronson M; Pollett A; Eiriksson LR; Oza AM; Gallinger S; Lerner-Ellis J; Alvandi Z; Bernardini MQ; MacKay HJ; Mojtahedi G; Tone AA; Massey C; Clarke BA
    Cancer; 2014 Dec; 120(24):3932-9. PubMed ID: 25081409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large genomic rearrangements and germline epimutations in Lynch syndrome.
    Gylling A; Ridanpää M; Vierimaa O; Aittomäki K; Avela K; Kääriäinen H; Laivuori H; Pöyhönen M; Sallinen SL; Wallgren-Pettersson C; Järvinen HJ; Mecklin JP; Peltomäki P
    Int J Cancer; 2009 May; 124(10):2333-40. PubMed ID: 19173287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A validation of models for prediction of pathogenic variants in mismatch repair genes.
    Shyr C; Blackford AL; Huang T; Ke J; Ouardaoui N; Trippa L; Syngal S; Ukaegbu C; Uno H; Nafa K; Stadler ZK; Offit K; Amos CI; Lynch PM; Chen S; Giardiello FM; Buchanan DD; Hopper JL; Jenkins MA; Southey MC; Win AK; Figueiredo JC; Braun D; Parmigiani G
    Genet Med; 2022 Oct; 24(10):2155-2166. PubMed ID: 35997715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.
    Chui MH; Ryan P; Radigan J; Ferguson SE; Pollett A; Aronson M; Semotiuk K; Holter S; Sy K; Kwon JS; Soma A; Singh N; Gallinger S; Shaw P; Arseneau J; Foulkes WD; Gilks CB; Clarke BA
    Am J Surg Pathol; 2014 Sep; 38(9):1173-81. PubMed ID: 25025451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.